BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo W, Wu Z, Chen J, Guo S, You W, Wang S, Ma J, Wang H, Wang X, Wang H, Ma J, Yang Y, Tian Y, Shi Q, Gao T, Yi X, Li C. Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis. J Immunother Cancer 2022;10:e004381. [PMID: 35738798 DOI: 10.1136/jitc-2021-004381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Xiang Q, Zhao Y, Li W. Identification and validation of ferroptosis-related gene signature in intervertebral disc degeneration. Front Endocrinol (Lausanne) 2023;14:1089796. [PMID: 36814575 DOI: 10.3389/fendo.2023.1089796] [Reference Citation Analysis]
2 Zeng L, Gowda BHJ, Ahmed MG, Abourehab MAS, Chen ZS, Zhang C, Li J, Kesharwani P. Advancements in nanoparticle-based treatment approaches for skin cancer therapy. Mol Cancer 2023;22:10. [PMID: 36635761 DOI: 10.1186/s12943-022-01708-4] [Reference Citation Analysis]
3 Shao K, Shen H, Chen X, Shao Z, Liu Y, Wang Y, Chen H, Wu X. Copper transporter gene ATP7A: A predictive biomarker for immunotherapy and targeted therapy in hepatocellular carcinoma. Int Immunopharmacol 2023;114:109518. [PMID: 36502594 DOI: 10.1016/j.intimp.2022.109518] [Reference Citation Analysis]
4 John C, Jain K, Masanam HB, Narasimhan AK, Natarajan A. Recent Trends and Opportunities for the Targeted Immuno-Nanomaterials for Cancer Theranostics Applications. Micromachines (Basel) 2022;13. [PMID: 36557516 DOI: 10.3390/mi13122217] [Reference Citation Analysis]
5 Wang H, Zhang H, Chen Y, Wang H, Tian Y, Yi X, Shi Q, Zhao T, Zhang B, Gao T, Guo S, Li C, Guo W. Targeting Wnt/β-Catenin Signaling Exacerbates Ferroptosis and Increases the Efficacy of Melanoma Immunotherapy via the Regulation of MITF. Cells 2022;11. [PMID: 36429010 DOI: 10.3390/cells11223580] [Reference Citation Analysis]
6 Dai S, Li F, Long H, Zhou Z, Luo H, Xu S, Gao L. Relationship between miRNA and ferroptosis in tumors. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.977062] [Reference Citation Analysis]
7 Viegas JSR, Bentley MVLB, Vicentini FTMDC. Challenges to perform an efficiently gene therapy adopting non-viral vectors: Melanoma landscape. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103964] [Reference Citation Analysis]
8 Mulens-arias V, Nicolás-boluda A, Carn F, Gazeau F. Cationic Polyethyleneimine (PEI)–Gold Nanocomposites Modulate Macrophage Activation and Reprogram Mouse Breast Triple-Negative MET-1 Tumor Immunological Microenvironment. Pharmaceutics 2022;14:2234. [DOI: 10.3390/pharmaceutics14102234] [Reference Citation Analysis]
9 Rhim J, Baek W, Seo Y, Kim JH. From Molecular Mechanisms to Therapeutics: Understanding MicroRNA-21 in Cancer. Cells 2022;11:2791. [DOI: 10.3390/cells11182791] [Reference Citation Analysis]
10 Xl L, Gy Z, R G, N C. Ferroptosis in sepsis: The mechanism, the role and the therapeutic potential. Front Immunol 2022;13:956361. [DOI: 10.3389/fimmu.2022.956361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]